其一线抗高血压药缬沙坦(valsartan，Diovan)已通过瑞典医药产品局(Medical Products Agency，MPA)的审批，用于治疗新近发生过心肌梗死的高危患者。此为本品该新适应证在欧盟的首次获准。
基于4个网页-相关网页
即使他们的产品通过了食品医药管理局(FDA)的安全测试，他们也不得不面对成堆的州法院的医疗诉讼。
Even if their products have been deemed safe by the Food and Drug Administration (FDA), they have long faced the threat of liability lawsuits in state courts.
更加危险的是全科医生\家庭医生将转而给妇女使用其他同类药物以替代帕罗西汀。 最近美国食品和药物管理局（FDA）和英国医药和保健产品管理局（MHRA）已就此危险发出警告。
The danger with recent warnings from the FDA and MHRA about Seroxat is that GPs will switch women to another drug of the same class.
英国药物与医药保健产品监管局已经收到了类似案例的报告，并且要求健康专员密切关注。
The Medicines and Healthcare products Regulatory Agency has already received reports of such cases and has asked health professionals to watch out for more.
应用推荐